7X2-29577-56046
4 vaccinations
8 coded responses
42 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 481 / MI
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Registered in v-safe
-
2021-01-29
Dose 1 — Pfizer-BioNTech
- 2021-01-29
-
2021-01-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
-
2021-02-19
Dose 2 — Pfizer-BioNTech
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-05-21
- 2021-08-20
-
2021-09-29
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Swelling · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tirednessFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tirednessFree text: Dizziness - lightheadedMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Dizziness — Feeling: Fair · Site: Redness, Itching · Fatigue or tirednessFree text: Intermittent light-headed and/or dizzinessMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Survey response — day 7, dose 3MedDRA: Dizziness — Feeling: Fair · Site: Redness, Swelling · Fatigue or tirednessFree text: Intermittent lightheadinessMedDRA releases: 2024-11 · check-in free text available
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-12
- 2021-12-31
-
2022-03-30
Survey response — 6 months, dose 3MedDRA: Uterine polyp — Feeling: GoodFree text: Uterine polyps were found.MedDRA releases: 2024-11 · check-in free text available
- 2022-09-29
-
2022-10-18
Dose 4 — Pfizer-BioNTech
- 2022-10-18
-
2022-10-19
Survey response — days 1–6 daily, dose 4MedDRA: Immunisation reaction — Feeling: GoodFree text: I received a bivalent booster about a month ago so this report is NOT related to the time immediately after I was boosted. I had a moderate reaction to the booster that lasted about a week.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-21
Survey response — days 1–6 daily, dose 4MedDRA: Adverse reaction — Feeling: GoodFree text: I had my vaccination booster about a month ago and had a fairly substantial reaction that lasted about a week. So the information I am entering now in the vsafe system is not directly connected to my most recent bivalent booster.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-22
Survey response — days 1–6 daily, dose 4MedDRA: Adverse reaction — Feeling: GoodFree text: I feel fine today and have been completing the survey with information about my current condition. That said I had my buy variant Covid booster about a month ago and at that time had a moderately difficult reaction that lasted about a week.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-01
- 2022-11-10
- 2022-11-15
- 2022-11-22
- 2022-11-29
- 2023-01-17
- 2023-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-10-18 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Dizziness
Systemic reaction (other): Dizziness - lightheaded
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Intermittent light-headed and/or dizziness
Release 10 — day 7, dose 3
Systemic reaction (other): Intermittent lightheadiness
Release 11 — 6 months, dose 3
Symptoms: Uterine polyps were found.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): I received a bivalent booster about a month ago so this report is NOT related to the time immediately after I was boosted. I had a moderate reaction to the booster that lasted about a week.
Systemic reaction (other): I had my vaccination booster about a month ago and had a fairly substantial reaction that lasted about a week. So the information I am entering now in the vsafe system is not directly connected to my most recent bivalent booster.
Systemic reaction (other): I feel fine today and have been completing the survey with information about my current condition. That said I had my buy variant Covid booster about a month ago and at that time had a moderately difficult reaction that lasted about a week.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Uterine polyp | · | · | ✓ |
| SRO | Adverse reaction | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Immunisation reaction | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release